𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioavailability of three phenytoin preparations in healthy subjects and in epileptics

✍ Scribed by B. Rambeck; H. -E. Boenigk; E. Stenzel

Publisher
Springer
Year
1977
Tongue
English
Weight
734 KB
Volume
12
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

PHARMACOKINETICS AND ABSOLUTE BIOAVAILAB
PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY OF EPRISTERIDE IN HEALTHY MALE SUBJECTS
✍ Lisa Jo Benincosa; Patricia R. Audet; Dave Lundberg; NΓ©vine Zariffa; Diane K. Jo πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

The objective of the current investigation was to describe the pharmacokinetics and absolute oral bioavailability of epristeride. Twelve healthy male subjects (mean (SD) age, 27 (6.2) years) received a single oral dose of 5mg and an intravenous infusion of 4.5 mg over 30 min in a crossover fashion.

The relationship between buspirone bioav
The relationship between buspirone bioavailability and dose in healthy subjects
✍ Dr. R. E. Gammans; R. F. Mayol; A. V. MacKenthun; L. F. Sokya πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

Dose dependency of the pharmacokinetics of buspirone, a new anxiolytic agent, was tested in 24 healthy volunteers. Each subject received 10, 20, and 40 mg doses according to a randomized, three-way crossover design with a 7-day interval between treatments. Buspirone AUC values at 10, 20, and 40 mg d